- Reference Pages
- Search Agencies
- Search Topics
Throughout 2018 and 2019, NIEHS provided funding for small businesses developing technologies of interest to the Tox21 program. The funding was offered as part of the 2018 and 2019 Omnibus Solicitations of NIH, Centers for Disease Control, and FDA for small business grant applications to support development and commercialization of innovative technologies. Technologies supported by NIEHS included improved or expanded testing methods for toxicity screening, computational approaches for predictive toxicology, and other technologies such as alternative or improved methods for fixing and preserving tissues.
In addition to funding offered via the Omnibus Solicitations, NIEHS offers grants to support development of specific types of technologies targeting specific endpoints. Funding offered in 2018 and 2019 supported development of: